Vivos (RDGL) Total Non-Current Liabilities (2013 - 2025)
Vivos (RDGL) reported Total Non-Current Liabilities of $88851.0 for Q4 2025, up 96.31% on a YoY basis from $45260.0 in Q4 2024, and up 96.31% sequentially from $45260.0 in Q4 2024.
Vivos (RDGL) Total Non-Current Liabilities (2013 - 2025) Analysis & Trends
Vivos (RDGL) has 8 years of Total Non-Current Liabilities data on file, last reported at $88851.0 in Q4 2025.
- For the quarter ending Q4 2025, Total Non-Current Liabilities rose 96.31% year-over-year to $88851.0; the trailing twelve-month figure through Dec 2025 stood at $88851.0 (up 96.31% YoY), and the FY2025 full-year result was $88851.0, up 96.31% from the prior year.
- Total Non-Current Liabilities improved to $88851.0 in Q4 2025, from $45260.0 in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $97369.0 in Q3 2023 to a low of $45260.0 in Q4 2024.
- A 3-year average of $77160.0 and a median of $88851.0 in 2025 frame the typical range for Total Non-Current Liabilities.
- Peak annual rise in Total Non-Current Liabilities reached 96.31% in 2025, while the deepest fall reached 96.31% in 2025.
- Tracing RDGL's Total Non-Current Liabilities over 3 years: stood at $97369.0 in 2023, then tumbled by 53.52% to $45260.0 in 2024, then surged by 96.31% to $88851.0 in 2025.
- Business Quant data shows RDGL's Total Non-Current Liabilities at $88851.0 in Q4 2025, $45260.0 in Q4 2024, and $97369.0 in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 3.53 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 24.21 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 3.57 Bn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 9.85 Bn |
| 10 | Vivos | 27.16 Mn | 25.60 Mn | -3,105.00 | 88,851.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 88,851.00 |
| Dec 31, 2024 | 45,260.00 |
| Sep 30, 2023 | 97,369.00 |
| Dec 31, 2018 | -3.86 Mn |
| Jun 30, 2017 | 3.51 Mn |
| Mar 31, 2017 | 3.14 Mn |
| Dec 31, 2016 | 2.74 Mn |
| Jun 30, 2016 | 3.05 Mn |
| Mar 31, 2016 | 4.60 Mn |
| Dec 31, 2015 | 4.88 Mn |
| Jun 30, 2013 | 7.66 Mn |